ABT Rating

ABT Intrinsic Value

Key Highlights:
As of Mar 18, 2025 ABT Relative Value is $144.1, which is undervalued by 14.1%, compared to current share price of $126.3.
As of Mar 18, 2025 ABT DCF Value is $213.3, which is undervalued by 68.9%, compared to current share price of $126.3.
Methodology
Price per share, $
Current share price
126.3

ABT Share Price History

1W (4.8%)
1M (3.0%)
6M 11.0%
YTD 17.9%
1Y 14.6%
3Y 9.3%
5Y 74.0%
10Y 222.4%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!

ABT Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$218.2B
Shares Outstanding
1,727M
Employees
114K
Valuation (LTM)
Return on Capital
30.4%
17.2%
25.3%
21.0%
Earnings

ABT Stock Financials

ABT Income Statement Metrics

Annual
Quarterly
LTM

Revenue

$42.0B +4.6% YoY

Operating Income

$6.8B +5.4% YoY

Net Income

$13.4B +134.2% YoY

ABT Cash Flow Statement Metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$8,558.0M +17.9% YoY

Capital Expenditure (CAPEX)

($2,207.0M) +0.2% YoY

Free Cash Flow (FCF)

$6,351.0M +25.5% YoY

ABT Income Statement Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$42.0B 4.6% YoY
$23.2B 5.0% YoY
55.4% margin
Cost of revenue
$18.7B 4.1% YoY
Operating income
$6,825.0M 5.4% YoY
16.3% margin
Other: $403.0M
Net interest: $215.0M
Operating expenses
$16.4B 4.9% YoY
Pre-tax income
$7,013.0M 5.2% YoY
16.7% margin
Net income
$13.4B 134.2% YoY
31.9% margin
R&D
$2,844.0M 3.8% YoY
6.8% of revenue
SG&A
$11.7B 6.8% YoY
27.9% of revenue

ABT Balance Sheet Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$81.4B
Current assets ($23.7B, 29.1% of total)
$7,967.0M (9.8%)
$9,495.0M (11.7%)
Other current assets
$6,194.0M (7.6%)
Non-current assets ($57.8B, 70.9% of total)
$886.0M (1.1%)
$6,647.0M (8.2%)
Other non-current assets
$39.6B (48.6%)
Financial position
$7,054.0M
$7,967.0M$15.0B
Cash & Short-term Investments
Total Debt

ABT Stock Ratios

ABT Earnings Surprises

Crunching data... Almost there!

ABT Dividends

ABT Dividend Yield

Crunching data... Almost there!

ABT Dividend Per Share

Competing with ABT

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Quality rating
Intrinsic value
1Y Return
Revenue
Free Cash Flow
Revenue growth
FCF margin
Gross margin
ROIC
Total Debt to Equity
$218.2B
7.1
$179.7
42.3% undervalued
14.6%
$42.0B
$6,351.0M
4.6%
15.1%
55.6%
25.3%
31.4%
$144.9B
6.8
$36.6
63.1% overvalued
47.6%
$16.7B
$2,438.0M
17.6%
14.6%
67.0%
8.0%
50.7%
$142.2B
6.5
$302.5
19.5% overvalued
7.1%
$22.6B
$3,487.0M
10.2%
15.4%
62.8%
10.4%
65.9%
$118.8B
6.4
$116.4
26.3% undervalued
14.0%
$33.2B
$5,467.0M
2.7%
16.5%
62.9%
7.4%
53.6%
$41.5B
6.1
$54.4
22.6% overvalued
(24.2%)
$5,724.3M
$289.9M
(4.7%)
5.1%
78.4%
21.6%
7.0%
$28.0B
7.3
$39.7
43.9% overvalued
(47.5%)
$4,033.0M
$630.7M
11.3%
15.6%
60.4%
21.7%
120.3%
$24.4B
5.3
$69.1
162.7% undervalued
31.5%
€18.0B
€1,145.0M
(0.8%)
6.4%
43.1%
(4.2%)
63.4%
$22.6B
5.8
$179.6
59.1% undervalued
(9.6%)
$7,678.6M
$1,132.4M
3.8%
14.7%
66.0%
6.3%
43.0%
$22.4B
6.4
$196.3
14.0% overvalued
0.3%
$5,398.4M
$751.4M
(0.2%)
13.9%
44.7%
8.2%
35.6%
$18.0B
7.9
$106.7
59.0% overvalued
51.7%
$1,900.3M
$303.0M
12.0%
15.9%
76.4%
26.9%
6.9%
$12.7B
6.0
$68.3
137.3% undervalued
10.9%
$11.4B
$787.0M
8.9%
6.9%
69.9%
14.5%
63.1%

FAQ

What is Abbott Laboratories (ABT) stock rating?

As of today, Abbott Laboratories has a stock rating of 7 (out of 10), which is considered Great.

is Abbott Laboratories (ABT) a good stock to buy?

As of today, Abbott Laboratories has a Great stock rating, which is 42.3% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.